1. Home
  2. PFSA vs PIII Comparison

PFSA vs PIII Comparison

Compare PFSA & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFSA
  • PIII
  • Stock Information
  • Founded
  • PFSA 2009
  • PIII 2015
  • Country
  • PFSA United States
  • PIII United States
  • Employees
  • PFSA N/A
  • PIII N/A
  • Industry
  • PFSA Medical/Dental Instruments
  • PIII Medical/Nursing Services
  • Sector
  • PFSA Health Care
  • PIII Health Care
  • Exchange
  • PFSA Nasdaq
  • PIII Nasdaq
  • Market Cap
  • PFSA 25.1M
  • PIII 28.6M
  • IPO Year
  • PFSA N/A
  • PIII N/A
  • Fundamental
  • Price
  • PFSA $0.31
  • PIII $8.77
  • Analyst Decision
  • PFSA
  • PIII Strong Buy
  • Analyst Count
  • PFSA 0
  • PIII 3
  • Target Price
  • PFSA N/A
  • PIII $17.50
  • AVG Volume (30 Days)
  • PFSA 6.7M
  • PIII 7.3K
  • Earning Date
  • PFSA 08-14-2025
  • PIII 08-14-2025
  • Dividend Yield
  • PFSA N/A
  • PIII N/A
  • EPS Growth
  • PFSA N/A
  • PIII N/A
  • EPS
  • PFSA N/A
  • PIII N/A
  • Revenue
  • PFSA $75,000.00
  • PIII $1,461,823,000.00
  • Revenue This Year
  • PFSA N/A
  • PIII N/A
  • Revenue Next Year
  • PFSA N/A
  • PIII $9.46
  • P/E Ratio
  • PFSA N/A
  • PIII N/A
  • Revenue Growth
  • PFSA 66.67
  • PIII 4.20
  • 52 Week Low
  • PFSA $0.30
  • PIII $5.80
  • 52 Week High
  • PFSA $5.50
  • PIII $29.19
  • Technical
  • Relative Strength Index (RSI)
  • PFSA N/A
  • PIII 72.11
  • Support Level
  • PFSA N/A
  • PIII $8.08
  • Resistance Level
  • PFSA N/A
  • PIII $8.78
  • Average True Range (ATR)
  • PFSA 0.00
  • PIII 0.46
  • MACD
  • PFSA 0.00
  • PIII 0.14
  • Stochastic Oscillator
  • PFSA 0.00
  • PIII 93.31

About PFSA Profusa Inc. Common Stock

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

Share on Social Networks: